|

HepB mAb19 Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Pipeline

Phase 1: 3

Top Sponsors

  • Aarhus University Hospital2
  • Rockefeller University1

Indications

  • Liver Disease3
  • Hepatitis B2
  • Hepatitis B Chronic Infection1
  • Hepatitis B Virus1
  • Hepatitis D, Chronic1

Other2 trials

Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
Phase 1
Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection
Phase 1

New York, New York1 trial

HepB mAb19 in Individuals With Chronic Hepatitis B Infection

NYU Langone Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.